Junqiang Yin

2.0k total citations
79 papers, 1.5k citations indexed

About

Junqiang Yin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Rheumatology. According to data from OpenAlex, Junqiang Yin has authored 79 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 25 papers in Molecular Biology and 22 papers in Rheumatology. Recurrent topics in Junqiang Yin's work include Sarcoma Diagnosis and Treatment (42 papers), Bone Tumor Diagnosis and Treatments (21 papers) and Cancer Genomics and Diagnostics (6 papers). Junqiang Yin is often cited by papers focused on Sarcoma Diagnosis and Treatment (42 papers), Bone Tumor Diagnosis and Treatments (21 papers) and Cancer Genomics and Diagnostics (6 papers). Junqiang Yin collaborates with scholars based in China, Hong Kong and United States. Junqiang Yin's co-authors include Xianbiao Xie, Changye Zou, Gang Huang, Jingnan Shen, Changye Zou, Qinglian Tang, Zhiqiang Zhao, Jingnan Shen, Weihai Liu and Jingnan Shen and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Junqiang Yin

78 papers receiving 1.5k citations

Peers

Junqiang Yin
Yihui Shi United States
Joshua J. Souchek United States
Ajay Matta Canada
Krzysztof Moroz United States
Kyoung Min Kim South Korea
Junqiang Yin
Citations per year, relative to Junqiang Yin Junqiang Yin (= 1×) peers Isabella T. Tai

Countries citing papers authored by Junqiang Yin

Since Specialization
Citations

This map shows the geographic impact of Junqiang Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqiang Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqiang Yin more than expected).

Fields of papers citing papers by Junqiang Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junqiang Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqiang Yin. The network helps show where Junqiang Yin may publish in the future.

Co-authorship network of co-authors of Junqiang Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Junqiang Yin. A scholar is included among the top collaborators of Junqiang Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junqiang Yin. Junqiang Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yu, Fei Wu, Xuelin Zhang, et al.. (2024). SNPs Give LACTB Oncogene‐Like Functions and Prompt Tumor Progression via Dual‐Regulating p53. Advanced Science. 11(43). e2405907–e2405907. 2 indexed citations
2.
Tu, Jian, Zhiqiang Zhao, Tiao Lin, et al.. (2024). Comparison of oncological and functional outcomes in Lower-limb osteosarcoma pediatric patients: a large single-center retrospective cohort study. International Journal of Surgery. 110(7). 4208–4220. 3 indexed citations
3.
Zhang, Zhen, Chunlin Huang, Liying Wang, et al.. (2024). Hybrid gelatin-ascorbyl phosphate scaffolds accelerate diabetic wound healing via ROS scavenging, angiogenesis and collagen remodeling. Biomaterials Advances. 158. 213779–213779. 23 indexed citations
5.
Zou, Changye, Tiao Lin, Jian Tu, et al.. (2024). Age-dependent molecular variations in osteosarcoma: implications for precision oncology across pediatric, adolescent, and adult patients. Frontiers in Oncology. 14. 1382276–1382276. 5 indexed citations
6.
Han, Shuyan, et al.. (2023). Therapeutic Copolymer from Salicylic Acid and l-Phenylalanine as a Nanosized Drug Carrier for Orthotopic Breast Cancer with Lung Metastasis. ACS Applied Materials & Interfaces. 15(35). 41743–41754. 14 indexed citations
7.
Zhao, Zhiqiang, Tiao Lin, Gang Huang, et al.. (2023). Preoperative denosumab treatment in patients with giant cell bone tumors in limbs: A retrospective study using propensity score matching. Cancer Medicine. 12(11). 12041–12049. 4 indexed citations
8.
Xie, Xianbiao, Haomiao Li, Junqiang Yin, et al.. (2022). A Comprehensive Understanding of the Genomic Bone Tumor Landscape: A Multicenter Prospective Study. Frontiers in Oncology. 12. 835004–835004. 9 indexed citations
9.
Zhang, Jiajun, Weihai Liu, Changye Zou, et al.. (2020). Targeting Super-Enhancer–Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor. Clinical Cancer Research. 26(11). 2681–2692. 44 indexed citations
10.
Liao, Dan, Li Zhong, Junqiang Yin, et al.. (2020). Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma. Nature Cell Biology. 22(7). 868–881. 47 indexed citations
11.
Liao, Dan, Li Zhong, Junqiang Yin, et al.. (2020). Author Correction: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma. Nature Cell Biology. 22(7). 907–907. 1 indexed citations
12.
Yin, Junqiang, Zhenhua Gao, Changye Zou, et al.. (2020). A Novel Method to Treat Progressive Desmoid Tumors Involving Neurovascular Bundles: A Retrospective Cohort Study. Neurosurgery. 88(6). 1095–1102. 2 indexed citations
13.
14.
Huang, Gang, Xianbiao Xie, Junqiang Yin, et al.. (2015). Establishment and assessment of a nomogram for predicting the individual prognosis of osteosarcoma. Zhonghua guke zazhi. 35(2). 133–141. 1 indexed citations
15.
Wen, Li‐Li, Yang Huang, Wan Huang, et al.. (2014). Anti-Inflammatory and Antinociceptive Activities of Bufalin in Rodents. Mediators of Inflammation. 2014. 1–9. 48 indexed citations
16.
Yong, Bicheng, Junqiang Yin, Changye Zou, et al.. (2012). Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma. World Journal of Surgical Oncology. 10(1). 191–191. 2 indexed citations
17.
Yong, Bicheng, et al.. (2012). Survival analysis of 311 patients with osteosarcoma of the extremities treated in a single institute. Zhonghua guke zazhi. 32(11). 1032–1039. 2 indexed citations
18.
Zou, Changye, Bicheng Yong, Longjuan Zhang, et al.. (2012). Expression and prognostic relevance of PRAME in primary osteosarcoma. Biochemical and Biophysical Research Communications. 419(4). 801–808. 46 indexed citations
19.
Tang, Qinglian, Xianbiao Xie, Junqiang Yin, et al.. (2011). Enrichment of osteosarcoma stem cells by chemotherapy. Chinese Journal of Cancer. 426–432. 1 indexed citations
20.
Zou, Changye, Jin Wang, Jingnan Shen, et al.. (2008). Establishment and characteristics of two syngeneic human osteosarcoma cell lines from primary tumor and skip metastases. Acta Pharmacologica Sinica. 29(3). 325–332. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026